Immune thrombocytopenia caused by glycoprotein IIb/IIIa inhibitors.

Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management. J Thromb Haemost (2009) 2.04

Cooperative integrin/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo. Blood (2012) 1.72

Antibodies causing thrombocytopenia in patients treated with RGD-mimetic platelet inhibitors recognize ligand-specific conformers of αIIb/β3 integrin. Blood (2012) 1.46

Pathobiology of secondary immune thrombocytopenia. Semin Hematol (2009) 1.35

Eptifibatide-induced thrombocytopenia and thrombosis in humans require FcgammaRIIa and the integrin beta3 cytoplasmic domain. J Clin Invest (2009) 1.24

Approach to the diagnosis and management of drug-induced immune thrombocytopenia. Transfus Med Rev (2013) 1.20

Application of high-throughput screening to identify a novel alphaIIb-specific small- molecule inhibitor of alphaIIbbeta3-mediated platelet interaction with fibrinogen. Blood (2007) 1.11

Integrin-based therapeutics: biological basis, clinical use and new drugs. Nat Rev Drug Discov (2016) 1.06

Drug-induced thrombocytopenia. Hematol Oncol Clin North Am (2007) 1.01

Activation-independent, antibody-mediated removal of GPVI from circulating human platelets: development of a novel NOD/SCID mouse model to evaluate the in vivo effectiveness of anti-human platelet agents. Blood (2006) 1.00

Evaluation of the effect of partial splenic embolization on platelet values for liver cirrhosis patients with thrombocytopenia. World J Gastroenterol (2007) 0.99

Severe thrombocytopenia following tirofiban infusion. Indian J Pharmacol (2011) 0.97

Glycoprotein IIb/IIIa inhibitor-induced thrombocytopenia: diagnosis and treatment. Clin Res Cardiol (2006) 0.92

A review of the role of anticoagulation in the treatment of peripheral arterial disease. Int J Angiol (2012) 0.85

Translating from the rivers of Babylon to the coronary bloodstream. J Clin Invest (2012) 0.85

Eptifibatide-induced thrombocytopenia: with thrombosis and disseminated intravascular coagulation immediately after left main coronary artery percutaneous coronary angioplasty. Tex Heart Inst J (2012) 0.82

Vanishing platelets: rapid and extreme tirofiban-induced thrombocytopenia after percutaneous coronary intervention for acute myocardial infarction. Tex Heart Inst J (2010) 0.81

Acute profound thrombocytopenia with second exposure to eptifibatide associated with a strong antibody reaction. Platelets (2009) 0.80

Drug-induced thrombocytopenia for the hospitalist physician with a focus on heparin-induced thrombocytopenia. Hosp Pract (1995) (2010) 0.75

Tirofiban-Induced Thrombocytopenia Occurring with Crohn's Disease. Case Rep Cardiol (2016) 0.75

Eptifibatide and Cirrhosis: Rethinking GPIIb-IIIa Inhibitors for Acute Coronary Syndrome in the Setting of Liver Dysfunction. Cardiol Res (2014) 0.75

Eptifibatide-induced acute profound thrombocytopenia: a case report. BMC Res Notes (2014) 0.75

Abciximab: a reappraisal of its use in coronary care. Biologics (2008) 0.75

Thromboembolic events secondary to tirofiban-induced thrombocytopenia being treated with thrombopoietin: A case report. Exp Ther Med (2016) 0.75